Poniard Pharmaceuticals Stock Number Of Employees
Poniard Pharmaceuticals fundamentals help investors to digest information that contributes to Poniard Pharmaceuticals' financial success or failures. It also enables traders to predict the movement of Poniard Pink Sheet. The fundamental analysis module provides a way to measure Poniard Pharmaceuticals' intrinsic value by examining its available economic and financial indicators, including the cash flow records, the balance sheet account changes, the income statement patterns, and various microeconomic indicators and financial ratios related to Poniard Pharmaceuticals pink sheet.
Poniard |
Poniard Pharmaceuticals Company Number Of Employees Analysis
Poniard Pharmaceuticals' Number of Employees shows the total number of permanent full time and part time employees working for a given company and processed through its payroll.
Current Poniard Pharmaceuticals Number Of Employees | 7 |
Most of Poniard Pharmaceuticals' fundamental indicators, such as Number Of Employees, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, Poniard Pharmaceuticals is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.
Employee typically refers to an individual working under a contract of employment, whether oral or written, express or implied, and has recognized his or her rights and duties. Most officers of corporations are included as employees and contractors are generally excluded.
CompetitionBased on the recorded statements, Poniard Pharmaceuticals is currently employing 7.0 people. This is 99.94% lower than that of the Biotechnology sector and 98.69% lower than that of the Health Care industry. The number of employees for all United States stocks is 99.96% higher than that of the company.
Poniard Number Of Employees Peer Comparison
Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses Poniard Pharmaceuticals' direct or indirect competition against its Number Of Employees to detect undervalued stocks with similar characteristics or determine the pink sheets which would be a good addition to a portfolio. Peer analysis of Poniard Pharmaceuticals could also be used in its relative valuation, which is a method of valuing Poniard Pharmaceuticals by comparing valuation metrics of similar companies.Poniard Pharmaceuticals is currently under evaluation in number of employees category among its peers.
Poniard Fundamentals
Return On Equity | -2.1 | ||||
Return On Asset | -0.46 | ||||
Current Valuation | 434.76 K | ||||
Shares Outstanding | 1.5 M | ||||
Number Of Shares Shorted | 47.72 K | ||||
Price To Earning | (0.01) X | ||||
Price To Book | 0.1 X | ||||
EBITDA | (13.04 M) | ||||
Net Income | (30.05 M) | ||||
Cash And Equivalents | 1.98 M | ||||
Cash Per Share | 1.32 X | ||||
Total Debt | 1.57 M | ||||
Debt To Equity | 0.53 % | ||||
Current Ratio | 0.76 X | ||||
Book Value Per Share | 2.08 X | ||||
Cash Flow From Operations | (24.28 M) | ||||
Short Ratio | 2.56 X | ||||
Earnings Per Share | (3.79) X | ||||
Target Price | 1.0 | ||||
Beta | 0.9 | ||||
Market Capitalization | 29 | ||||
Total Asset | 11.64 M | ||||
Retained Earnings | (438.94 M) | ||||
Working Capital | 3.6 M | ||||
Current Asset | 5.22 M | ||||
Current Liabilities | 1.62 M | ||||
Z Score | -55.1 | ||||
Net Asset | 11.64 M |
Also Currently Popular
Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.Check out Your Equity Center to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in metropolitan statistical area. You can also try the Efficient Frontier module to plot and analyze your portfolio and positions against risk-return landscape of the market..
Other Consideration for investing in Poniard Pink Sheet
If you are still planning to invest in Poniard Pharmaceuticals check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the Poniard Pharmaceuticals' history and understand the potential risks before investing.
Idea Breakdown Analyze constituents of all Macroaxis ideas. Macroaxis investment ideas are predefined, sector-focused investing themes | |
Portfolio Anywhere Track or share privately all of your investments from the convenience of any device | |
Alpha Finder Use alpha and beta coefficients to find investment opportunities after accounting for the risk | |
Bond Analysis Evaluate and analyze corporate bonds as a potential investment for your portfolios. | |
My Watchlist Analysis Analyze my current watchlist and to refresh optimization strategy. Macroaxis watchlist is based on self-learning algorithm to remember stocks you like | |
Share Portfolio Track or share privately all of your investments from the convenience of any device | |
Commodity Directory Find actively traded commodities issued by global exchanges | |
Portfolio Analyzer Portfolio analysis module that provides access to portfolio diagnostics and optimization engine | |
Global Markets Map Get a quick overview of global market snapshot using zoomable world map. Drill down to check world indexes |